查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
类器官市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按器官类型、应用、来源、类型和地理位置
市场调查报告书
商品编码
1372515

类器官市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按器官类型、应用、来源、类型和地理位置

Organoids Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Organ Type, Application, Source, Type, and Geography
出版日期: | 出版商: The Insight Partners | 英文 190 Pages | 订单完成后即时交付

价格

类器官市场预计将从2022年的25.07亿美元成长到2030年的122.06亿美元；预计2022 年至2030 年复合年增长率为21.9%。对肿瘤建模和生物库的更高需求、个性化药物的日益采用以及对开发动物测试模型替代品的日益关注推动了类器官市场的增长。类器官市场趋势包括将类器官与晶片上的器官结合。

类器官是源自干细胞的微小、自组织、三维组织培养物。这种培养物可以被精心设计来复製器官的大部分复杂性或表达其选定的方面，例如仅产生某些类型的细胞。类器官由干细胞生长而成，这些细胞可以无限分裂并产生不同类型的细胞作为其后代的一部分。类器官的大小范围从小于头髮的宽度到五毫米。

许多在类器官市场运营的市场参与者和研究机构正在开发先进技术，以扩大其产品组合併增加其市场份额。以下提到了与类器官相关的一些最新进展：

2020 年 11 月，Cellesce Ltd. 与 Manchester BIOGEL 建立合作伙伴关係，开发全合成的非动物三维 (3D) 支架，该支架可以模仿人体的生理环境，并能够製造、扩大规模并提高重复性源自患者的类器官。

2020 年 11 月，Cellesce Ltd. 与 Manchester BIOGEL 建立合作伙伴关係，开发全合成的非动物三维 (3D) 支架，该支架可以模仿人体的生理环境，并能够製造、扩大规模并提高重复性源自患者的类器官。

因此，这一发展可能会在预测期内为类器官市场带来新的趋势。

对新药和先进药物不断增长的需求正在推动药物发现和研究的整体步伐。根据 ClinicalTrials.gov 统计，2020 年临床试验研究总数估计为 356,282 项。休布雷希特研究所最近的一项调查表明，类器官可以透过识别不太可能从该药物中受益的患者来使昂贵的药物更具成本效益。全球范围内越来越多的临床试验预计将推动对先进医疗技术（包括类器官模型）的需求。

此外，药物发现中的类器官不仅限于癌症，它们还用于其他疾病，例如囊性纤维化、多囊性肾病变、小头畸形以及肠道和气道传染病。例如，类器官可以概括器官的特性，例如器官结构和功能。此外，类器官可以恢復组织或器官的原始遗传和表观遗传状态，使它们适合基因编辑。各种研究显示了将 CRISPR-Cas9 技术与类器官结合的积极成果，这为囊性纤维化的突破提供了更多机会。根据2020 年发表的一项研究“基于CRISPR 的腺嘌呤编辑器纠正囊性纤维化类器官生物库中的无义突变”，囊性纤维化类器官生物库代表了664 名患者，其中约20%理论上能够有效修復无义突变透过腺嘌呤碱基编辑器在囊性纤维化跨膜导体受体中。儘管基因编辑类器官在一些动物模型中取得了一些成果，但其效率明显较低，成功率不高。因此，研究和开发基因编辑类器官的安全性、长期稳定性和功能性的方法至关重要。

此外，COVID-19 大流行引发了开发人类肺类器官模型的需求。例如，MilliporeSigma 开发了 3dGRO 人类肺类器官培养系统，使研究人员能够控制、存取和复製器官组织，以培养人类肺上皮类器官模型，从而有助于在研究过程中获得积极和成功的结果。

因此，此类创新预计将为类器官市场的成长提供更重要的成长机会。

基于应用程式的见解

根据应用，类器官市场分为发育生物学、传染病的疾病病理学、再生医学、药物毒性和功效测试、药物发现和个人化医疗等。到 2022 年，发育生物学占据最大的市场份额，药物发现和个人化医疗预计在预测期内复合年增长率最高。

基于来源的见解

根据来源，类器官市场分为多能干细胞和器官特异性成体干细胞。多能干细胞细分市场到 2022 年将占据更大的市场份额，预计在预测期内复合年增长率将更高。

世界卫生组织（WHO）、美国人口普查局和美国国家医学图书馆是在准备类器官市场报告时提到的一些主要的一手和二手来源。

基于类型的见解

根据类型，类器官市场分为仪器、消耗品和服务。 2022 年，消耗品领域将占据更大的市场份额，预计在预测期内复合年增长率将更高。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解
  • 市场吸引力

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：类器官市场格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 欧洲PEST分析
    • 亚太地区 PEST 分析
    • 南美洲和中美洲 PEST 分析
    • 中东和非洲 PEST 分析

第 5 章：类器官市场 - 主要产业动态

  • 主要市场驱动因素：
    • 对肿瘤建模和生物样本库的需求不断增长
    • 越来越多地采用个人化药物
    • 人们日益关注开发动物测试模型的替代方案
  • 主要市场限制：
    • 与将类器官纳入现有工作流程相关的问题
    • 缺乏熟练的专业人员
  • 主要市场机会：
    • 专注于药物发现活动
  • 未来的趋势：
    • 将类器官与器官晶片结合
  • 影响分析：

第 6 章：类器官市场 - 全球市场分析

  • 类器官市场收入，2022 - 2030

第 7 章：全球类器官市场 - 2030 年收入与预测 - 按器官类型

  • 概述
  • 2022 年和 2030 年按器官类型分類的类器官市场收入份额 (%)
  • 胃
  • 肠
  • 肝
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第 8 章：全球类器官市场 - 2030 年收入与预测 -按应用

  • 概述
  • 类器官市场收入份额，按应用划分 2022 年和 2030 年 (%)
  • 发育生物学
  • 传染病的疾病病理学
  • 再生医学
  • 药物毒性和药效测试
  • 药物发现与个人化医疗
  • 其他的

第 9 章：全球类器官市场 - 收入和 2030 年预测 - 按来源

  • 概述
  • 2022 年及 2030 年类器官市场收入份额（按来源划分）
  • 多能干细胞
  • 器官特异性成体干细胞

第 10 章：全球类器官市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 类器官市场收入份额，按类型 2022 年和 2030 年 (%)
  • 仪器
  • 耗材
  • 服务

第 11 章：类器官市场 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：Covid-19 前后的影响

  • Covid-19 前后的影响

第 13 章：类器官市场产业格局

  • 概述
  • 市场上公司采取的成长策略，(%)
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 14 章：类器官市场、主要公司概况

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • 3Dnamics Inc.
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero

第 15 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00017616

The organoids market is expected to grow from US$ 2.507 billion in 2022 to US$ 12.206 billion by 2030; it is estimated to register a CAGR of 21.9% from 2022 to 2030. The higher demand for tumor modeling and biobanking, growing adoption of personalized drugs, and rising focus on developing alternatives for animal testing models drive the organoids market growth. The organoids market trends include combining organoids with organ-on-a-chip.

The organoids are tiny, self-organized, three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ or to express selected aspects of it, like producing only certain types of cells. Organoids grow from stem cells-cells that can divide indefinitely and produce different types of cells as part of their progeny. Organoids can range in size from less than the width of a hair to five millimeters.

Many market players and research institutes operating in the organoids market are developing advanced technologies to expand their product portfolios and increase their market shares. A few of the recent developments related to organoids are mentioned below:

In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.

In November 2020, Cellesce Ltd. entered a partnership with Manchester BIOGEL for the development of fully synthetic animal-free three-dimensional (3D) scaffolds that mimic the physiological environment in the human body and enable the manufacture, scale up, and improved reproducibility of patient-derived organoids.

Thus, the development is likely to introduce new trends in the organoids market during the forecast period.

The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.

Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ's original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study 'CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,' published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids' safety, long-term stability, and functionality.

Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research.

Thus, such innovations are expected to offer more significant growth opportunities for organoids market growth.

Application-Based Insights

Based on application, the organoids market is divided into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. In 2022, the developmental biology held the largest share of the market and drug discovery & personalized medicine is anticipated to register the highest CAGR during the forecast period.

Source-Based Insights

Based on source, the organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.

The World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine are a few of the major primary and secondary sources referred to while preparing the report on the organoids market.

Type-Based Insights

Based on type, the organoids market is bifurcated into instruments, consumables, and services. The consumables segment held a larger share of the market in 2022 and is expected to record at a higher CAGR during the forecast period.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the organoids market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Organoids Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis

5. Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - Global Market Analysis

  • 6.1 Organoids Market Revenue (US$ Mn), 2022 - 2030

7. Global Organoids Market - Revenue and Forecast to 2030 - by Organ Type

  • 7.1 Overview
  • 7.2 Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Organoids Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Organoids Market - Revenue and Forecast to 2030 - by Source

  • 9.1 Overview
  • 9.2 Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. Organoids Market - Geographical Analysis

  • 11.1 North America Organoids Market, Revenue And Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America Organoids Market, by Organ Type
    • 11.1.4 North America Organoids Market, by Application
    • 11.1.5 North America Organoids Market, by Source
    • 11.1.6 North America Organoids Market, by Type
    • 11.1.7 North America Organoids Market, by Country
      • 11.1.7.1 US
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.1.3 US Organoids Market, by Organ Type
        • 11.1.7.1.4 US Organoids Market, by Application
        • 11.1.7.1.5 US Organoids Market, by Source
        • 11.1.7.1.6 US Organoids Market, by Type
      • 11.1.7.2 Canada
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.2.3 Canada Organoids Market, by Organ Type
        • 11.1.7.2.4 Canada Organoids Market, by Application
        • 11.1.7.2.5 Canada Organoids Market, by Source
        • 11.1.7.2.6 Canada Organoids Market, by Type
      • 11.1.7.3 Mexico
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.3.3 Mexico Organoids Market, by Organ Type
        • 11.1.7.3.4 Mexico Organoids Market, by Application
        • 11.1.7.3.5 Mexico Organoids Market, by Source
        • 11.1.7.3.6 Mexico Organoids Market, by Type
  • 11.2 Europe Organoids Market, Revenue And Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe Organoids Market, by Organ Type
    • 11.2.4 Europe Organoids Market, by Application
    • 11.2.5 Europe Organoids Market, by Source
    • 11.2.6 Europe Organoids Market, by Type
    • 11.2.7 Europe Organoids Market by Country
      • 11.2.7.1 Germany
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.1.3 Germany Organoids Market, by Organ Type
        • 11.2.7.1.4 Germany Organoids Market, by Application
        • 11.2.7.1.5 Germany Organoids Market, by Source
        • 11.2.7.1.6 Germany Organoids Market, by Type
      • 11.2.7.2 UK
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 UK Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.2.3 UK Organoids Market, by Organ Type
        • 11.2.7.2.4 UK Organoids Market, by Application
        • 11.2.7.2.5 UK Organoids Market, by Source
        • 11.2.7.2.6 UK Organoids Market, by Type
      • 11.2.7.3 France
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 France Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.3.3 France Organoids Market, by Organ Type
        • 11.2.7.3.4 France Organoids Market, by Application
        • 11.2.7.3.5 France Organoids Market, by Source
        • 11.2.7.3.6 France Organoids Market, by Type
      • 11.2.7.4 Italy
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.4.3 Italy Organoids Market, by Organ Type
        • 11.2.7.4.4 Italy Organoids Market, by Application
        • 11.2.7.4.5 Italy Organoids Market, by Source
        • 11.2.7.4.6 Italy Organoids Market, by Type
      • 11.2.7.5 Spain
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.5.3 Spain Organoids Market, by Organ Type
        • 11.2.7.5.4 Spain Organoids Market, by Application
        • 11.2.7.5.5 Spain Organoids Market, by Source
        • 11.2.7.5.6 Spain Organoids Market, by Type
      • 11.2.7.6 Rest of Europe
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.6.3 Rest of Europe Organoids Market, by Organ Type
        • 11.2.7.6.4 Rest of Europe Organoids Market, by Application
        • 11.2.7.6.5 Rest of Europe Organoids Market, by Source
        • 11.2.7.6.6 Rest of Europe Organoids Market, by Type
  • 11.3 Asia Pacific Organoids Market, Revenue And Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific Organoids Market, by Organ Type
    • 11.3.4 Asia Pacific Organoids Market, by Application
    • 11.3.5 Asia Pacific Organoids Market, by Source
    • 11.3.6 Asia Pacific Organoids Market, by Type
    • 11.3.7 Asia Pacific Organoids Market by Country
      • 11.3.7.1 China
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.1.3 China Organoids Market, by Organ Type
        • 11.3.7.1.4 China Organoids Market, by Application
        • 11.3.7.1.5 China Organoids Market, by Source
        • 11.3.7.1.6 China Organoids Market, by Type
      • 11.3.7.2 Japan
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.2.3 Japan Organoids Market, by Organ Type
        • 11.3.7.2.4 Japan Organoids Market, by Application
        • 11.3.7.2.5 Japan Organoids Market, by Source
        • 11.3.7.2.6 Japan Organoids Market, by Type
      • 11.3.7.3 India
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.3.3 India Organoids Market, by Organ Type
        • 11.3.7.3.4 India Organoids Market, by Application
        • 11.3.7.3.5 India Organoids Market, by Source
        • 11.3.7.3.6 India Organoids Market, by Type
      • 11.3.7.4 Australia
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.4.3 Australia Organoids Market, by Organ Type
        • 11.3.7.4.4 Australia Organoids Market, by Application
        • 11.3.7.4.5 Australia Organoids Market, by Source
        • 11.3.7.4.6 Australia Organoids Market, by Type
      • 11.3.7.5 South Korea
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.5.3 South Korea Organoids Market, by Organ Type
        • 11.3.7.5.4 South Korea Organoids Market, by Application
        • 11.3.7.5.5 South Korea Organoids Market, by Source
        • 11.3.7.5.6 South Korea Organoids Market, by Type
      • 11.3.7.6 Rest of Asia Pacific
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.6.3 Rest of Asia Pacific Organoids Market, by Organ Type
        • 11.3.7.6.4 Rest of Asia Pacific Organoids Market, by Application
        • 11.3.7.6.5 Rest of Asia Pacific Organoids Market, by Source
        • 11.3.7.6.6 Rest of Asia Pacific Organoids Market, by Type
  • 11.4 Middle East & Africa Organoids Market, Revenue and Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa Organoids Market, by Organ Type
    • 11.4.4 Middle East & Africa Organoids Market, by Application
    • 11.4.5 Middle East & Africa Organoids Market, by Source
    • 11.4.6 Middle East & Africa Organoids Market, by Type
    • 11.4.7 Middle East & Africa Organoids Market by Country
      • 11.4.7.1 Saudi Arabia
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.1.3 Saudi Arabia Organoids Market, by Organ Type
        • 11.4.7.1.4 Saudi Arabia Organoids Market, by Application
        • 11.4.7.1.5 Saudi Arabia Organoids Market, by Source
        • 11.4.7.1.6 Saudi Arabia Organoids Market, by Type
      • 11.4.7.2 UAE
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.2.3 UAE Organoids Market, by Organ Type
        • 11.4.7.2.4 UAE Organoids Market, by Application
        • 11.4.7.2.5 UAE Organoids Market, by Source
        • 11.4.7.2.6 UAE Organoids Market, by Type
      • 11.4.7.3 South Africa
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.3.3 South Africa Organoids Market, by Organ Type
        • 11.4.7.3.4 South Africa Organoids Market, by Application
        • 11.4.7.3.5 South Africa Organoids Market, by Source
        • 11.4.7.3.6 South Africa Organoids Market, by Type
      • 11.4.7.4 Rest of Middle East & Africa
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.4.3 Rest of Middle East & Africa Organoids Market, by Organ Type
        • 11.4.7.4.4 Rest of Middle East & Africa Organoids Market, by Application
        • 11.4.7.4.5 Rest of Middle East & Africa Organoids Market, by Source
        • 11.4.7.4.6 Rest of Middle East & Africa Organoids Market, by Type
  • 11.5 South & Central America Organoids Market, Revenue and Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America Organoids Market, by Organ Type
    • 11.5.4 South & Central America Organoids Market, by Application
    • 11.5.5 South & Central America Organoids Market, by Source
    • 11.5.6 South & Central America Organoids Market, by Type
    • 11.5.7 South & Central America Organoids Market by Country
      • 11.5.7.1 Brazil
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.1.3 Brazil Organoids Market, by Organ Type
        • 11.5.7.1.4 Brazil Organoids Market, by Application
        • 11.5.7.1.5 Brazil Organoids Market, by Source
        • 11.5.7.1.6 Brazil Organoids Market, by Type
      • 11.5.7.2 Argentina
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.2.3 Argentina Organoids Market, by Organ Type
        • 11.5.7.2.4 Argentina Organoids Market, by Application
        • 11.5.7.2.5 Argentina Organoids Market, by Source
        • 11.5.7.2.6 Argentina Organoids Market, by Type
      • 11.5.7.3 Rest of South & Central America
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.3.3 Rest of South & Central America Organoids Market, by Organ Type
        • 11.5.7.3.4 Rest of South & Central America Organoids Market, by Application
        • 11.5.7.3.5 Rest of South & Central America Organoids Market, by Source
        • 11.5.7.3.6 Rest of South & Central America Organoids Market, by Type

12. Pre & Post Covid-19 Impact

  • 12.1 Pre & Post Covid-19 Impact

13. Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Hubrecht Organoid Technology
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Definigen
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Organoid Therapeutics
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 3Dnamics Inc.
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Thermo Fisher Scientific Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Corning Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Merck KGaA
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 InSphero
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Organoids Market Segmentation
  • Table 2. North America Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. North America Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Application
  • Table 4. North America Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Source
  • Table 5. North America Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 6. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 8. US Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 9. US Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 10. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 12. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 13. Canada Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 14. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 15. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 16. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 17. Mexico Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 18. Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 19. Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Application
  • Table 20. Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Source
  • Table 21. Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 22. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 23. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 24. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 25. Germany Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 26. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 27. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 28. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 29. UK Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 30. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 31. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 32. France Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 33. France Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 34. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 35. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 36. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 37. Italy Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 38. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 39. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 40. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 41. Spain Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 42. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 43. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 44. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 45. Rest of Europe Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 46. Asia Pacific Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 47. Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Application
  • Table 48. Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Source
  • Table 49. Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 50. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 51. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 52. China Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 53. China Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 54. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 55. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 56. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 57. Japan Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 58. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 59. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 60. India Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 61. India Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 62. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Organ Type
  • Table 63. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 64. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Source
  • Table 65. Australia Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 66. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 67. South Korea Organoids Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 68. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 69. South Korea Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 70. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) -Organ Type
  • Table 71. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 72. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn) Source
  • Table 73. Rest of Asia Pacific Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 74. Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 75. Middle East & Africa Organoids Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 76. Middle East & Africa Organoids Market Revenue and Forecast To 2030 (US$ Mn) - Source
  • Table 77. Middle East & Africa Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 78. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 79. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 80. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 81. Saudi Arabia Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 82. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 83. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 84. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 85. UAE Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 86. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 87. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 88. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 89. South Africa Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 90. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 91. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 92. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 93. Rest of Middle East & Africa Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 94. South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 95. South & Central America Organoids Market Revenue and Forecast To 2030 (US$ Mn) - Application
  • Table 96. South & Central America Organoids Market Revenue and Forecast To 2030 (US$ Mn) - Source
  • Table 97. South & Central America Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 98. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 99. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 100. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 101. Brazil Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 102. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 103. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 104. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 105. Argentina Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 106. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 107. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 108. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 109. Rest of South & Central America Organoids Market Revenue And Forecast To 2030 (US$ Mn) - Type
  • Table 110. Organic Developments Done by Companies
  • Table 111. Inorganic Developments Done by Companies
  • Table 112. Glossary of Terms, Organoids Market

List Of Figures

  • Figure 1. Organoids Market Segmentation, By Geography
  • Figure 2. North America - PEST Analysis
  • Figure 3. Europe - PEST Analysis
  • Figure 4. Asia Pacific - PEST Analysis
  • Figure 5. South & Central America - PEST Analysis
  • Figure 6. Middle East & Africa - PEST Analysis
  • Figure 7. Organoids Market - Key Industry Dynamics
  • Figure 8. Impact Analysis of Drivers and Restraints
  • Figure 9. Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 10. Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 11. Stomach: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Intestine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Liver: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Pancreas: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Lung: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Brain: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Kidney: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 20. Developmental Biology: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Disease Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Regenerative Medicine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Others: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 27. Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Organ-specific Adult Stem Cells: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 30. Instruments: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Consumables: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Services: Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Organoids Market, 2022 ($Mn)
  • Figure 34. North America Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. North America Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 36. US Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 37. Canada Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. Mexico Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 39. Europe Organoids Market, By Geography, 2022 ($Mn)
  • Figure 40. Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 41. Europe Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 42. Germany Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 43. UK Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. France Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 45. Italy Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. Spain Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Europe Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 48. Organoids Market, By Geography, 2022 ($Mn)
  • Figure 49. Asia Pacific Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 50. Asia Pacific Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 51. China Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 52. Japan Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 53. India Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 54. Australia Organoids Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 55. South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. Organoids Market, By Geography, 2022 And 2030 ($Mn)
  • Figure 58. Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Middle East & Africa Organoids Market, By Key Countries, 2022 And 2030 (%)
  • Figure 60. Saudi Arabia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. UAE Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 62. South Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 63. Rest of Middle East & Africa Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 64. Organoids Market, By Geography, 2022 ($Mn)
  • Figure 65. South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 66. South & Central America Organoids Market, By Key Countries, 2022 and 2030 (%)
  • Figure 67. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 68. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 69. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 70. Pre & Post Covid-19 Impact
  • Figure 71. Growth Strategies Done by the Companies in the Market, (%)